Exact Sciences Corp (EXAS)

36.60
2.51 7.36
NASDAQ : Health Care
Prev Close 34.09
Open 34.34
Day Low/High 33.86 / 36.60
52 Wk Low/High 4.67 / 25.07
Volume 3.17M
Avg Volume 3.48M
Exchange NASDAQ
Shares Outstanding 111.19M
Market Cap 3.89B
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Exact Sciences Stock Falls on Secondary Stock Sale

Exact Sciences Stock Falls on Secondary Stock Sale

The secondary offering, to be underwritten by Jefferies, Bank of America/Merrill Lynch and Robert W. Baird, would offer 7 million shares.

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Plus more from the biotechnology world on Wednesday, June 7.

Exact Sciences: Cramer's Top Takeaways

Exact Sciences: Cramer's Top Takeaways

Kevin Conroy, chairman, president and CEO at Exact Sciences, tells Jim Cramer about his company's non-invasive test for colon cancer.

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Profits Trump Economic Weakness: Cramer's 'Mad Money' Recap (Friday 6/2/17)

Jim Cramer has the game plan for next week, including earnings from Thor Industries and HD Supply.

Blackberry, Exact Sciences, Splunk, Freeport-McMoRan: 'Mad Money' Lightning Round

Blackberry, Exact Sciences, Splunk, Freeport-McMoRan: 'Mad Money' Lightning Round

Jim Cramer focuses on Blackberry, Exact Sciences, Splunk, Freeport-McMoRan and more.

Get Your Head Into the Cloud: Cramer's 'Mad Money' Recap (Monday 5/22/17)

Get Your Head Into the Cloud: Cramer's 'Mad Money' Recap (Monday 5/22/17)

Jim Cramer says it's more than just the cloud. There are some astounding moves in the broader tech sector, too.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Exact Sciences Corporation

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ("Exact" or the "Company") (Nasdaq: EXAS).

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Apple CEO says fund will boost advanced manufacturing in U.S.

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Aetna now offers commercial coverage of Exact Sciences' Cologuard test.

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

Exact Sciences And Mayo Clinic Study Shows Promise Of New Blood-based Lung Cancer Test

AACR abstract highlights methylation markers capable of detecting all types of lung cancer with more than 90% sensitivity and specificity

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.

CMS Proposes Inclusion Of Cologuard In Medicare Advantage Star Ratings

Cologuard offers health plans an opportunity to increase screening & improve quality ratings